155 related articles for article (PubMed ID: 11738482)
1. Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors.
Molderings GJ; Bönisch H; Hammermann R; Göthert M; Brüss M
Neurochem Int; 2002 Feb; 40(2):157-67. PubMed ID: 11738482
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels.
Molderings GJ; Göthert M
Fundam Clin Pharmacol; 1998; 12(4):388-97. PubMed ID: 9711460
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship.
Molderings GJ; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):157-64. PubMed ID: 10494885
[TBL] [Abstract][Full Text] [Related]
5. Effects of imidazolines on noradrenaline release in brain: an investigation into their relationship to imidazoline, alpha 2 and H3 receptors.
Schlicker E; Fink K; Kathmann M; Molderings GJ; Göthert M
Neurochem Int; 1997 Jan; 30(1):73-83. PubMed ID: 9116590
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Ihenetu K; Molleman A; Parsons ME; Whelan CJ
Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
[TBL] [Abstract][Full Text] [Related]
7. A search for presynaptic imidazoline receptors at rabbit and rat noradrenergic neurones in the absence of alpha 2-autoinhibition.
Gaiser EG; Trendelenburg AU; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):123-32. PubMed ID: 10048597
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
Ihenetu K; Molleman A; Parsons M; Whelan C
Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic imidazoline receptors. New developments in characterization and classification.
Göthert M; Brüss M; Bönisch H; Molderings GJ
Ann N Y Acad Sci; 1999 Jun; 881():171-84. PubMed ID: 10415912
[TBL] [Abstract][Full Text] [Related]
11. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.
Molderings GJ; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):507-16. PubMed ID: 7643914
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
Terranova JP; Michaud JC; Le Fur G; Soubrié P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
[TBL] [Abstract][Full Text] [Related]
15. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Gustafsson K; Christensson B; Sander B; Flygare J
Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
[TBL] [Abstract][Full Text] [Related]
17. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
19. Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.
Göthert M; Molderings GJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):271-82. PubMed ID: 1678140
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain.
Mato S; Pazos A; Valdizán EM
Eur J Pharmacol; 2002 May; 443(1-3):43-6. PubMed ID: 12044790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
